AlloVir Announces Pricing of Upsized Initial Public Offering
CAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) — AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, today announced […]
Kura Oncology to Report Second Quarter 2020 Financial Results
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the […]
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2020 Earnings and Company Updates
CAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing […]
Pacira to Report Second Quarter 2020 Financial Results on Thursday August 6, 2020
PARSIPPANY, N.J., July 30, 2020 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second […]
resTORbio Provides Corporate Update and Reports Second Quarter 2020 Financial Results
BOSTON, July 30, 2020 (GLOBE NEWSWIRE) — resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target […]
SIGA Announces Marketing Authorization Filing for oral tecovirimat with the European Medicines Agency for Multiple Indications
– Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications –NEW YORK, July 30, 2020 (GLOBE NEWSWIRE) — SIGA […]
InflaRx Reports Q2 2020 Financial & Operating Results
Announced encouraging results from the Phase II portion of the Phase II/III adaptive, randomized, controlled trial in patients with COVID-19 […]
Zai Lab to Announce Financial Results for the Six Months Ended June 30, 2020 and Corporate Updates
— Company to host Conference Call and Webcast on August 13, 2020 at 8:00 a.m. ET —SHANGHAI and SAN FRANCISCO, […]
Muscle Maker Grill Opens First of Five Delivery-Only Ghost Kitchens in Chicago
Fast-casual brand opens first delivery-only ghost kitchen in ChicagoBurleson, Texas, July 30, 2020 (GLOBE NEWSWIRE) — Muscle Maker, Inc. (Nasdaq: […]
Kiniksa Reports Second Quarter 2020 Financial Results and Highlights Recent Pipeline and Corporate Activity
– Rilonacept pivotal Phase 3 trial in recurrent pericarditis met statistical significance for primary and all major secondary efficacy endpoints; sBLA […]
